

Amogen Pharma Email Formats
Contact top employees from
Amogen Pharma
- Amogen Pharma uses 6 formats total. Most emails use firstNameInitiallastName: jdoe@amogenpharma.com. This shows up in about 87% of work addresses.
- Other common patterns:
- lastName → doe@amogenpharma.com
- firstNamelastNameInitial → janed@amogenpharma.com
Popular Amogen Pharma's Email Templates
| Amogen Pharma ’s Employees Email Address Formats | Percentage | |
|---|---|---|
Employees Email Address Formats firstNameInitiallastName | Percentage: 87% | |
Employees Email Address Formats firstNamelastNameInitial | Percentage: 5% | |
Employees Email Address Formats lastName | Percentage: 4% | |
Employees Email Address Formats lastName_firstNameInitial | Percentage: 2% | |
Employees Email Address Formats lastNameInitialfirstNameInitial | Percentage: 1% | |
Employees Email Address Formats lastName_firstName | Percentage: 1% |
Contact top employees from
Amogen Pharma
Manpreet Singh
President Business Development
sivananda Reddy
Head of Quality Assurance
Vasamsetti Haveela
Associate Researcher
RAJASHEKHAR HARIJANA DHONDA
Research And Development Associate
Jawad Baksh
Lead bioanalytical
Pavan Satya
Electrical Engineer
Abhinav Roddha
Accountant
Sahithya Gampa
Research And Development Associate
Akhilesh Raju Pusapati
Chief Executive Officer
Likhita Basava
Quality Assurance Analyst
G Sai Prashanthi
Research Associate
Swetha Karatampati
Downstream expert
Swathi Gubba
Human Resources Generalist
Narmada Chowdhary
Human Resources Manager
Rakesh Sutar
Research And Development Associate
Email Formats of Similar Companies
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.




